Business Context and Reporting Period
Company: Belite Bio, Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of March 2026
Key Event: On March 31, 2026, the company issued a press release announcing the availability of its Annual Report on Form 20-F via its website.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves solely as a notification regarding the availability of the Annual Report on Form 20-F, which contains the detailed financial data.
Material Changes
No material changes in financial performance or operations are detailed in this specific filing. The document references the attached press release (Exhibit 99.1) for the announcement of the annual report availability.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or contingencies. Investors are directed to the Annual Report on Form 20-F for comprehensive disclosures.
Key Facts for Investor Verification
- Verify the availability and content of the Annual Report on Form 20-F on the company's website.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the annual report release.
- Note that this Form 6-K is a procedural filing and does not contain standalone financial results.